Requires health insurance coverage for testing for BRCA1 and BRCA2 genes.

This New Jersey bill (A 3117) requires all health insurance plans sold in the state - including hospital service contracts, medical service plans, individual policies, group plans, and health maintenance organizations - to cover BRCA1 and BRCA2 genetic testing at no additional cost to the patient. It directly affects individuals seeking testing for these breast cancer-related genes, as well as all health insurers operating in New Jersey. The law mandates coverage "to the same extent as for any other medical condition," meaning patients won’t face extra out-of-pocket costs for this specific testing. It applies to all plans issued or renewed in New Jersey after the bill’s effective date.